Inhibition of testosterone metabolism in the human prostate.
D000726:Androgen Antagonists; D000731:Androstanes / Q000378:metabolism; D000813:Anilides / Q000494:pharmacology; D002250:Carbon Radioisotopes; D003534:Cyproterone / Q000494:pharmacology; D003900:Desoxycorticosterone / Q000494:pharmacology; D013196:Dihydrotestosterone / Q000378:metabolism; D004958:Estradiol / Q000494:pharmacology; D004964:Estriol / Q000494:pharmacology; D006801:Humans; D006845:Hydrocarbons, Fluorinated / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D008524:Medrogestone / Q000494:pharmacology*; D008525:Medroxyprogesterone / Q000494:pharmacology; D009574:Nitro Compounds / Q000494:pharmacology; D011374:Progesterone / Q000494:pharmacology; D011372:Progestins / Q000494:pharmacology*; D011467:Prostate / Q000378:metabolism*; D011470:Prostatic Hyperplasia / Q000378:metabolism; D013739:Testosterone / Q000378:metabolism*; D014316:Tritium
D000726:Androgen Antagonists; D000731:Androstanes; D000813:Anilides; D002250:Carbon Radioisotopes; D006845:Hydrocarbons, Fluorinated; D009574:Nitro Compounds; D011372:Progestins; D008524:Medrogestone; D013196:Dihydrotestosterone; D014316:Tritium; D013739:Testosterone; D003900:Desoxycorticosterone; D011374:Progesterone; D004958:Estradiol; D003534:Cyproterone; D004964:Estriol; D008525:Medroxyprogesterone